In order to perform in vitro testing of esterase inhibition caused by organophosphorous (OP) protoxicants, simple, reliable methods are needed to convert protoxicants to their esterase-inhibiting forms. Incubation of parathion or chlorpyrifos with 0.05% bromine solution or uninduced rat liver microsomes (RLM) resulted in production of the corresponding oxygen analogs of these OP compounds and markedly increased esterase inhibition in SH-SY5Y human neuroblastoma cells. Neither activation system affected cell viability or the activity of AChE or NTE in the absence of OP compounds. Although parathion and chlorpyrifos were activated by RLM, bromine activation required fewer steps and produced more esterase inhibition for a given concentration of chlorpyrifos. However, RLM activation of OP protoxicants produced metabolites other than oxygen analogs and may, therefore, be more relevant as a surrogate for OP biotransformation in vivo. This methodology makes the use of intact cells for in vitro testing of esterase inhibition caused by protoxicant organophosphate compounds a viable alternative to in vivo tests.
Organophosphorous (OP) compounds are economically important as pesticides, lubricants, and plasticizers. Esterase inhibition produced by OP exposure precedes both acute and delayed neurotoxicity. Acetylcholinesterase (AChE) inhibition is responsible for acute toxicity while neuropathy-target-esterase (NTE) inhibition is correlated with development of organophosphorous-induced delayed neuropathy (OPIDN) (for reviews, see Ecobichon, 1991; Lotti, 1992) . Current EPA guidelines for testing OP insecticides require that relative AChE and NTE inhibition be determined in brain and spinal cord of hens exposed to OP compounds (US EPA, 1991) . However, recent recommendations from the Interagency Coordinating Committee on the Validation of Alternative Methods encouraged federal agencies to use in vitro methods for toxicology testing where possible (NIEHS, 1997) .
In this context, neuroblastoma cells and primary cultures of neuronal-like cells have been investigated as in vitro models for testing of organophosphorous neurotoxicants. These cells possess both AChE and NTE activity (Fedalei and Nardone, 1983; Knoth Anderson et al., 1992; Nostrandt and Ehrich, 1992; Veronesi and Ehrich, 1993) . Using active esterase inhibitors, our laboratory recently demonstrated that esterase inhibition in neuroblastoma cells can be used to distinguish neuropathic OP compounds from those more likely to cause only acute toxicity by comparing relative sensitivities of AChE and NTE to OP-induced inhibition . Many OP compounds are protoxicants and must undergo metabolism before they affect esterase activity. Parathion, for example, has little effect on esterase activity, but conversion to paraoxon produces a potent AChE inhibitor and an acute neurotoxicant (Ecobichon, 1991) . Although potentially useful as in vitro models for screening OP compounds, neuroblastoma cell lines posses little or no capability to activate OP protoxicants. Previous studies did not measure esterase inhibition in neuroblastoma cells exposed to protoxicants (Ehrich et al., 1994; Ehrich et al., 1997; Ehrich and Correll, 1998) , in part because published methods for including metabolic activation, without affecting cell viability (Kohn and Durham, 1993) , were too complex for use in a microtiter-based, rapid screening system. Therefore, a simple and reliable exogenous activation system was needed before neuroblastoma cells could be used to quantify esterase inhibition caused by protoxicant OP compounds.
We have developed activation systems that are simple, effective, and do not affect cell viability or esterase activity. Bromine solution (0.05%) or uninduced rat liver microsomes (RLM) were used to activate parathion and chlorpyrifos prior to addition of these OP insecticides to SH-SY5Y human neuroblastoma cells. Both systems were capable of producing the oxygen analogs of parathion and chlorpyrifos, thus causing esterase inhibition, without affecting the viability of SH-SY5Y cells. These two activation systems were compared using metabolite production and extent of esterase inhibition in SH-SY5Y human neuroblastoma cells. chlorpyrifos (O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate, ChemServices, 99% pure), TCP (3,5,6-trichloro-2-pyridinol, Chem Services, 99% pure), and chlorpyrifos-oxon (O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate, DowElanco, Indianapolis, IN, 95.9% pure). These compounds were initially prepared as 0.1 M solutions in absolute ethanol. Final concentration of ethanol in cell suspensions was Յ1%. Vehicle controls had no effect on esterase activity or viability (as determined by trypan blue exclusion).
Cell culture. SH-SY5Y human neuroblastoma cells were obtained from the laboratory of Dr. J. R. Perez-Polo (University of Texas, Galveston). Cells (passages 40 -60) were grown in F12 Ham's medium containing 15% fetal bovine serum. Four days prior to harvest, differentiation was induced by addition of 20 M retinoic acid to the growth medium. This growth regimen was previously found to maximize basal AChE activity . Cells were harvested by incubation with Puck's saline containing 1 mM EDTA, collected by centrifugation, and resuspended at a density of 1 ϫ 10 7 cells/ml in phosphate buffered saline (PBS). At this time, cell viability was determined by trypan blue exclusion and found to be Ͼ85%. This suspension was used for determination of esterase activities.
Bromine activation. Bromine capsules (0.5 ml, 2% in water, Neogen Corp., Lansing, MI) were diluted 1:20 with distilled water to make a 0.1% solution of bromine in water. To activate parathion and chlorpyrifos, equal volumes of OP compounds in 100% ethanol (100 ϫ desired concentration in cells) and 0.1% bromine solution were mixed in a capped microcentrifuge tube and allowed to incubate for 3 min at room temperature. Preliminary experiments indicated that production of oxygen analogs was maximal at this time. Following activation, 20 L of bromine-OP mixture was added to 990 L of cell suspension and incubated for 1 h at 37°C.
Microsomal activation. Male Sprague-Dawley rats (200 -300 g) were killed by decapitation. Livers were removed and placed in ice-cold PBS. Microsomes were prepared according to the method of Guengerich (1982) and stored at Ϫ70°C until use. Total cytochrome P450 content of the microsomes was determined to be 1.76 Ϯ 0.13 nmol P450/mg microsomal protein (mean Ϯ SD, n ϭ 4) by the method of Omura and Sato (1964) . For RLM activation, 5 L of OP compounds (10000 ϫ desired concentration in cells) were added to 495 L of 0.1 M phosphate buffer pH 7.4 containing 1 mM NADPH, 3 mM EDTA and 1.0 mg microsomal protein. This suspension was incubated for 10 min at 37°C, conditions which maximized oxygen analog production in preliminary experiments. Incubations were terminated by extraction with 0.5 ml of ethyl acetate. Organic and aqueous phases were separated by centrifugation at 2000 ϫ g for 1 min. OP compounds and metabolites were recovered in the ethyl acetate phase. Recoveries of paraoxon and chlorpyrifos-oxon using this extraction protocol were 93 Ϯ 1.5% and 96 Ϯ 8%, respectively (mean Ϯ SD, n ϭ 3). Following activation, 10 L of the ethyl acetate phase was added to 990 L of cell suspension and incubated for 1 h at 37°C. Inclusion of ethyl acetate in these incubations did not affect cell viability, which was Ͼ85% by trypan blue exclusion.
Esterase activity. AChE and NTE activities in treated SH-SY5Y cells were determined using the microassay methods described by Correll and Ehrich (1991) . Activities were calculated from hydrolysis of substrate and are presented as percent of control esterase activity. Control AChE activity in SH-SY5Y suspensions was 13.1 Ϯ 2.8 nmol acetylthiocholine hydrolyzed/ min/mg protein (mean Ϯ SD, n ϭ 5). Control NTE activity in SH-SY5Y suspensions was 25.5 Ϯ 3.5 nmol phenyl valerate hydrolyzed/min/mg protein (mean Ϯ SD, n ϭ 5).
HPLC. OP compounds and metabolites were separated by HPLC using a C18 column (4.5 ϫ 250 mm Luna, Phenomenex, Torrance, CA) with gradient elution at 1.0 ml/min. Solvent A was acetonitrile, Solvent B was 10 mM phosphate buffer, pH 7.0. Gradient conditions were as follows: 0.0 min, 20% A; 2.0 min, 20% A; 15 min, 100% A; 25 min, 100% A. Compounds were quantified by UV absorbance (276 nm for parathion, 287 nm for chlorpyrifos). Peak purity was evaluated using a photodiode array detector (Model 9065, Varian Instrument Co., Sugar Land, TX). Using this system, parathion eluted at 17.6 min ( max , 274.2 nm). Parathion metabolites eluted as follows, paraoxon at 13.9 min ( max , 272.5 nm), p-nitrophenol at 11.9 min ( max , 315.2 nm. Chlorpyrifos eluted at 19.7 min ( max , 288.2 nm), TCP eluted at 8.8 min ( max , 321 nm), and chlorpyrifos-oxon eluted at 16.4 min ( max , 287.6 nm).
Data analysis.
Activities from each assay were converted to percent of control activity and mean Ϯ SEM was determined from n ϭ 3-7 assays for each concentration of OP compound. Data for concentrations of OP compound that produced activity between 10 -90% of control were used for linear regressions to calculate IC 50 values Ϯ 95% confidence intervals. These points were plotted using Prism (GraphPad Software, San Diego, CA).
FIG. 1. AChE inhibition in SH-
SY5Y human neuroblastoma cells incubated with parathion for 60 min at 37°C. Data were obtained following activation of parathion with 0.05% bromine solution (Br) or uninduced rat liver microsomes (RLM). Also depicted are data for parathion that did not undergo activation (parathion alone) and paraoxon, the oxygen analog of parathion that produces esterase inhibition. Values are mean Ϯ SEM (n ϭ 3-7). Apparent IC 50 values for AChE inhibition: paraoxon (4 Ϯ 10 nM), bromine activated parathion (17 Ϯ 5 nM), RLM activated parathion (21 Ϯ 6 nM).
RESULTS

Esterase inhibition
Neither parathion nor chlorpyrifos had an effect on AChE or NTE activity in SH-SY5Y cells in the absence of an activation system ( Figs. 1 and 2) . When parathion or chlorpyrifos were incubated with bromine or RLM prior to addition to cell suspensions, they produced dose-dependent esterase inhibition in SH-SY5Y cells. For a given concentration, bromine and RLM activated parathion produced equivalent AChE inhibition upon addition to SH-SY5Y cells, similar to that achieved with paraoxon ( Fig. 1) . AChE was more sensitive to inhibition by chlorpyrifos-oxon than NTE in SH-SY5Y cells. Bromine activation of chlorpyrifos produced AChE and NTE inhibition similar to the inhibition produced by equivalent concentrations of chlorpyrifos-oxon, while RLM activation of chlorpyrifos was significantly less effective (Fig. 2 ). Neither activation system had an effect on AChE or NTE activity in the absence of OP compounds (data not shown).
Oxygen analog production
Incubation of parathion and chlorpyrifos with bromine converted these phosphorothioates to their oxygen analogs. Bromine-activated parathion produced a single peak that eluted at 13.9 min with max of 272.5 nm (Fig. 3a) . Bromine-activated chlorpyrifos produced a single peak that eluted at 16.4 min with max of 287.6 nm (Fig. 3b) .
Incubation of OP compounds with RLM resulted in multiple metabolites. Chromatograms of parathion incubated with RLM contained major peaks that eluted at 11.9, 13.9, and 17.6 min, corresponding to p-nitrophenol, paraoxon, and parathion respectively (Fig. 3c) . Production of metabolites from 10 Ϫ5 M parathion incubated with 2 mg of RLM at 37°C peaked at 10 min (Fig 4a) .
Chromatograms of chlorpyrifos incubated with RLM contained major peaks that eluted at 8.8, 16.4, and 19.7 min, corresponding to TCP, chlorpyrifos-oxon and chlorpyrifos, respectively (Fig. 3d) . Production of metabolites from 10 Ϫ5 M chlorpyrifos incubated with 2 mg of RLM at 37°C peaked between 10 and 15 min (Fig 4b) .
FIG. 2. AChE and NTE inhibition in SH-SY5Y
human neuroblastoma cells incubated with chlorpyrifos for 60 min at 37°C. Data were obtained following activation of chlorpyrifos with 0.05% bromine solution (Cfs ϩ Br) or uninduced rat liver microsomes (Cfs ϩ RLM). Also depicted are data for chlorpyrifos that did not undergo activation (Cfs alone) and chlorpyrifos-oxon (Cfs-ox), the oxygen analog of chlorpyrifos that produces esterase inhibition. Closed symbols represent data for AChE inhibition; open symbols represent data for NTE inhibition. Values are mean Ϯ SEM (n ϭ 3-8). Apparent IC 50 for esterase inhibition: chlorpyrifos-oxon (AChE, 3 Ϯ 7 nM; NTE, 79 Ϯ 8 nM), bromine activated chlorpyrifos (AChE, 4 Ϯ 6 nM; NTE, 156 Ϯ 9 nM), RLM activated chlorpyrifos (AChE, 22 Ϯ 9 nM; NTE, 3100 Ϯ 13 nM).
DISCUSSION
The need for simple in vitro methods to test esterase inhibition produced by OP compounds requires that an adequate test system be developed. Neuroblastoma cells have been shown to be a suitable model for testing esterase inhibition . However, the lack of metabolic capability currently limits the use of cell culture systems for this purpose (Chambers, 1992; Ehrich et al., 1994; Ehrich and Correll, 1998; Veronesi et al., 1997) . The results presented in this paper demonstrate that bromine and RLM can be used as exogenous metabolizing systems, which, used in conjunction with neuroblastoma cells, allows in vitro testing of esterase inhibition caused by protoxicant OP compounds.
Previous work using S9 fraction as an exogenous metabolizing system determined that S9 fractions were toxic to neural cells during extended incubations (Kohn and Durham, 1993) . This toxicity was apparently due to the particulate nature of the S9 fraction and could be prevented by separating the S9 from the cells with a microporous tissue culture insert. Inclusion of 0.05% bromine or RLM extracts had no adverse effects on the Ϫ3 M chlorpyrifos incubated with 2 mg/ml RLM for 10 min at 37°C ( ϭ 287 nm). Identified metabolites are labeled. Peaks that are not identified were present in microsomal incubations that did not contain OP compounds. The TCP peak appears smaller than that of chlorpyrifos-oxon because the absorbance of TCP at 287 nm is 25% of its maximal absorbance at 321 nm. Absorbance at 287 nm was used to maximize sensitivity for chlorpyrifos-oxon.
viability of SH-SY5Y cells during short term incubations. While the current study did not use prolonged exposures, it is unlikely that use of bromine or RLM will produce toxicity during longer incubations, since these activation protocols do not add particulate components to the cell incubations.
Activation of parathion by bromine or RLM was equally effective (Fig. 1) . Activation of chlorpyrifos with bromine yields significantly more esterase inhibition than RLM activation (Fig. 2) . The reduced efficiency of RLM for chlorpyrifos activation may be due to lack of activation or increased detoxification. Atterberry et al. (1997) showed that desulfuration of chlorpyrifos by adult male rat liver microsomes was half that of parathion, while dearylation, a detoxification pathway, was nearly five times higher for chlorpyrifos-oxon than paraoxon. This is apparent as paraoxon and p-nitrophenol production from parathion were similar, but TCP production from chlorpyrifos was greater than chlorpyrifos-oxon (Fig. 4) . Decreased production and increased detoxification of chlorpyrifos-oxon in adult RLM, compared to paraoxon, explains the differences seen in activation of parathion and chlorpyrifos by RLM.
The presence of p-nitrophenol and TCP in RLM activated parathion and chlorpyrifos samples, respectively, indicates that dearylation occurred in these incubations (Figs. 3c and 3d) , reducing the concentration of oxygen analogs. Sultatos and Murphy (1983) reported that formation of p-nitrophenol and TCP in mouse liver microsomes containing 3 mM EDTA resulted from phosphorylation of microsomal protein. Despite inclusion of 3 mM EDTA in the microsomal incubations, much more TCP than chlorpyrifos-oxon was formed (Fig. 4) . Gil et al. (1994) determined that approximately 25% of paraoxonase activity in rat liver microsomes is EDTA-resistant. Therefore, p-nitrophenol and TCP formation in rat liver microsome incubations is probably a combination of esteratic cleavage and protein phosphorylation.
While both activation systems used in the present study produced significant esterase inhibition in SH-SY5Y cells at relevant concentrations of OP protoxicants, each system has advantages and disadvantages. Bromine activation is simple, inexpensive, and requires no animals. Ongoing work in our lab indicates that bromine will activate OP compounds other than parathion and chlorpyrifos (Ehrich and Correll, unpublished data) . However, bromine causes only oxidative desulfuration of the OP compounds, perhaps limiting its usefulness to those compounds whose active form is an oxygen analog. Some OP protoxicants are activated by other routes. Tri-o-tolyl phosphate (TOTP), for example, must be hydroxylated on a methyl group, then cyclized to form the active esterase inhibitor, tolyl saligenin phosphate (TSP) (Eto et al., 1967) . Bromine activa-
FIG. 3-Continued
tion lacks detoxification mechanisms, so an in vitro test system utilizing bromine activation to test OP protoxicants may overestimate the risk of esterase inhibition that would occur after in vivo exposure to OP protoxicants.
Microsomal activation produces metabolite profiles similar to those found in vivo, due to the presence of detoxification pathways. Another benefit of microsomal activation is the ability to activate those compounds that do not have active oxygen analogs, such as TOTP (Barber and Ehrich, unpublished data) . The presence of competing metabolic pathways during RLM results in lower net oxygen analog production than observed with bromine activation. A major detoxification enzyme for paraoxon and chlorpyrifos-oxon, paraoxonase, was partially inhibited by inclusion of 3 mM EDTA in order to maximize oxygen analog production. In vivo exposure to OP compounds will result in less esterase inhibition than predicted by RLM activation due to the activity of liver and serum paraoxonase.
In conclusion, we have demonstrated that bromine and RLM are effective methods of activating OP protoxicants for testing esterase inhibition in SH-SY5Y cells. These systems provide feasible in vitro alternatives to the current in vivo tests used for esterase inhibition caused by OP compounds and, because they utilize living cells, a valuable tool for mechanistic studies of the events that occur subsequent to esterase inhibition.
